Developer docs
API playgroundTry for free, no card

Search company profiles

Dr Lal PathLabs

Full company profile

uuid0004hn3

Namestring
Dr Lal PathLabs
Legal namestring
Dr Lal PathLabs Limited
Websiteurl
lalpathlabs.com
Company typeenum
Public
Founded yearint
1949
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersHaryana, India
HQ citystring
Haryana
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic pathology services, clinical laboratory testing, preventive health checkups, radiology imaging services, corporate health screening
Industry4 codes
1Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryYes
2Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry)
CodeHLAGAEABPrimaryNo
3Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
4Clinical Research & Trial Central Laboratories
CodeHLAFAMALPrimaryNo
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Pathology and Diagnostic Testing Services
TypeTransaction Fee
Description

Core revenue from pathology tests including blood tests, pathology panels, and health check-up packages offered to individual consumers and corporate clients through network of labs and collection centres.

lalpathlabs.com
2Radiology and Imaging Services
TypeTransaction Fee
Description

Revenue from radiology services including MRI, CT scan, X-ray, ultrasound, ECG, echocardiography, and mammography offered at diagnostic centres.

lalpathlabs.com
3SwasthFit GLP-1 Subscription Program
TypeSubscription Recurring
Description

Subscription-based monitoring program for Type 2 Diabetes and Obesity combining diagnostic testing with diet and exercise coaching. Four tiers ranging from 1-week to 12-month subscriptions.

lalpathlabs.com
4Corporate Healthcare Services
TypeProfessional Services
Description

Employee health check-up programs, drug tests, food handler check-ups, and pre-employment examinations for corporate clients across India.

lalpathlabs.com
5Sovaaka Premium Wellness Services
TypeSubscription Recurring
Description

Premium diagnostic experience centre offering personalized wellness programs, genetic testing, AI-supported imaging, and lifestyle-based healthcare with packages priced between Rs 11,000 and Rs 35,000.

healthcareexecutive.in
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details12 tiers
1SwasthFit Super 1 - Basic wellness package with 34 parameters
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Listed price Rs 3,530, discounted to Rs 1,870 (47% off)

lalpathlabs.com
2SwasthFit Super 2 - Intermediate wellness package with 57 parameters
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Listed price Rs 4,300, discounted to Rs 2,360 (45% off)

lalpathlabs.com
3SwasthFit Super 3 - Advanced wellness package with 36 parameters
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Listed price Rs 6,240, discounted to Rs 3,350 (46% off)

lalpathlabs.com
4SwasthFit Super 4 - Premium wellness package with 59 parameters
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Listed price Rs 7,010, discounted to Rs 4,040 (42% off)

lalpathlabs.com
5SwasthFit Complete Health Check - Comprehensive package with 106 parameters
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Listed price Rs 9,870, discounted to Rs 5,020 (49% off)

lalpathlabs.com
6SwasthFit GLP Screen - 1 week subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Offer price Rs 6,500 (from Rs 13,980). Includes 1 core diagnostic package, food and face scan, 1 dietician session.

lalpathlabs.com
7SwasthFit GLP Monitor - 3 months subscription
ModelSubscriptionBilling cadenceMonthly
Notes

Offer price Rs 11,500 (from Rs 24,480). Includes 1 core + 1 follow-up diagnostic package, food and face scan, 3 dietician sessions, 3 exercise coach sessions.

lalpathlabs.com
8SwasthFit GLP Sustain - 6 months subscription
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Offer price Rs 16,500 (from Rs 34,390). Includes 1 core + 2 follow-up diagnostic packages, food and face scan, 5 dietician sessions, 5 exercise coach sessions.

lalpathlabs.com
9SwasthFit GLP Total - 12 months subscription
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Offer price Rs 21,500 (from Rs 44,890). Includes 1 core + 3 follow-up diagnostic packages, food and face scan, 8 dietician sessions, 8 exercise coach sessions.

lalpathlabs.com
10Allergy Comprehensive Profile
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Rs 13,790 - comprehensive allergy testing including 100+ allergen panels

lalpathlabs.com
11Radiology Services - ECG/EKG
ModelUnit PricingBilling cadencePay-as-you-go
Notes

ECG test available at diagnostic centres with no special preparation required

lalpathlabs.com
12Radiology Services - Echocardiography
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Echo test priced at Rs 2,960

lalpathlabs.com
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1Sovaaka
Description

Premium wellness vertical / Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Programs include Eterna for women and Vita for men.

healthcareexecutive.in
+1 more record
Core offering1 text field

Dr Lal PathLabs operates a pan-India diagnostic services network offering pathology and radiology testing through 290+ laboratories, 6,600+ patient service centres, and 12,300+ pick-up points. The company provides over 5,000 tests and panels including routine blood tests, molecular diagnostics, genetic testing, imaging services (MRI, CT, X-ray, ultrasound, ECG, echocardiography), and bundled preventive health check-up packages such as SwasthFit and the premium Sovaaka vertical. Revenue is generated primarily through per-test and package fees for individual consumers, corporate health programs, and home sample collection services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 85.6M+ samples collected with 50+ quality checks per sample
+3 more records
Product overview1 text field

Dr Lal PathLabs operates as a comprehensive diagnostic services platform offering pathology and radiology testing across India. The core product portfolio includes SwasthFit bundled health checkup packages (Super 1-4, Complete Health Check), the AI-powered SwasthFit GLP-1 Program for diabetes and obesity management, and the premium wellness brand Sovaaka launched in January 2026. Supporting services include radiology imaging (MRI, CT, X-Ray, Ultrasound, Mammography, ECG, Echo), home collection, corporate tie-ups, and specialty testing programs including pregnancy packages, allergy testing, and the PrecisionCHD AI-enabled coronary heart disease test. The company processes samples through a network of 290+ clinical laboratories and over 6,600 patient service centres across India, with international operations in 14+ countries.

Product and service12 records
1Pathology Tests
CategoryPathology diagnostics
Description

Core diagnostic testing service offering over 5,000 tests and panels including blood tests, metabolic panels, infectious disease testing, cancer screening, genetic testing, molecular diagnostics, and specialized pathology services across all major disease categories. For individual consumers, hospitals, and referring doctors.

2Radiology Services
CategoryRadiology and imaging
Description

Comprehensive medical imaging services including MRI, CT Scan, X-Ray, Ultrasound, Mammography, ECG, Echo/2D Echo, TMT (Treadmill Test), Stress Echo, Holter monitoring, Pulmonary Function Test, Uroflowmetry, and OPG dental imaging. Available across the Delhi/NCR network for individual consumers and referring physicians.

3SwasthFit Health Check Packages
CategoryPreventive health check-ups
Description

Bundled health check-up packages including SwasthFit Super 1-4 (34-59 parameters) and SwasthFit Complete Health Check (106 parameters) covering diabetes, thyroid, heart health, and general wellness, with 40-49% discounts from list prices. Targeted at individual consumers for preventive screening.

4SwasthFit GLP-1 Program
CategorySubscription wellness program
Description

Subscription-based monitoring program for Type 2 Diabetes and Obesity management combining structured diagnostic testing (85+ parameters) with AI-enabled food scanning, face scan technology, dietician consultations, and exercise coaching. Four subscription tiers (1 week to 12 months) priced from Rs 6,500 to Rs 21,500. For individual consumers managing metabolic conditions.

5Sovaaka Premium Wellness
CategoryPremium preventive wellness
Description

Premium Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Doctor-designed programs include Eterna for women and Vita for men, with services like low-dose CT, 1.5T MRI, and DEXA scanning. Packages priced between Rs 11,000 and Rs 35,000. For affluent, wellness-focused consumers.

6Pregnancy Packages
CategorySpecialty diagnostics
Description

Specialized trimester-based pregnancy testing packages covering first, second, and third trimester including Pregnancy Package-6 (55 parameters) and Pregnancy Package-7 (42 parameters), for expectant mothers and obstetricians.

7Allergy Testing
CategorySpecialty diagnostics
Description

Comprehensive allergy testing including Allergy Comprehensive Profile (Rs 13,790 covering 100+ allergens), Food Intolerance Test (214 parameters), Immunoglobulin IgE, and specialized panels for dust, mold, milk, and food allergens. Over 100 allergy test types available. For individual consumers and referring physicians.

8Oncopro Cancer Diagnostics
CategorySpecialty diagnostics
Description

Oncology-focused diagnostic program offering cancer screening, tumor marker panels, and specialized oncology testing under the Oncopro brand, for individual consumers and referring oncologists.

9Diabetic Care Program
CategoryChronic disease management
Description

Structured diabetes care program combining diagnostic testing, monitoring, and lifestyle guidance for individuals managing Type 1 and Type 2 diabetes.

10Home Collection Service
CategoryDiagnostic service channel
Description

Home sample collection service allowing patients to book home visits for pathology sample collection. Includes prescription upload and callback request for test booking assistance, supporting convenience for individual consumers and elderly or mobility-limited patients.

11Corporate Health Programs
CategoryCorporate health services
Description

Corporate health screening solutions including annual checkups, pre-employment checkups, drug tests, food handler checkups, and COVID-related testing, with customized packages for corporate employees and families, available on-site and off-site. For HR teams, EHS functions, and corporate administration.

12PrecisionCHD Test
CategorySpecialty diagnostics
Description

Clinical blood test using epigenetics, genetics, and AI to detect coronary heart disease at the molecular level, including non-obstructive forms that standard angiograms typically cannot identify. Launched in January 2026 in partnership with Cardio Diagnostics and Aimil Ltd. for individual consumers and cardiologists.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

Strategic partnership to launch the PrecisionCHD test in India for detecting and managing coronary heart disease. This is Cardio Diagnostics' first expansion outside the United States. The test uses epigenetics, genetics, and AI technology to detect CHD at the molecular level, including non-obstructive forms that standard angiograms cannot identify. Initial phase integration into Dr. Lal PathLabs' network of over 290 clinical laboratories with commercial rollout expected in 2026.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-01-07
Description

Tripartite partnership with Cardio Diagnostics and Aimil Ltd. to launch PrecisionCHD test in India. Aimil serves as a distribution and implementation partner for the technology in the Indian market.

Strategic tierCoreTypeTechnology or Integration
Description

Digital transformation partnership implementing the Atellica Solution, Aptio Automation, and integrated IT tools at Dr. Lal PathLabs' national reference lab in Delhi. The implementation enabled reduction of total automation turnaround time by over 50%, reduced sample splitting by 93%, and improved Six Sigma assay performance. Partnership enables scalable, standardized workflows across the vast lab network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Integration with India's national digital health ecosystem, enabling patients to create ABHA (Ayushman Bharat Health Account) numbers and link their medical records. The platform supports 333M+ ABHA addresses created and 235M+ health records linked, enhancing digital health accessibility.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Partnership network in 14+ countries operating 90+ partners including hospitals and laboratories. Enables diagnostic services for patients and healthcare providers across international markets with 420+ tests per day conducted internationally.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Metropolis Healthcare is one of India's leading diagnostic chains with a comparable B2C and B2B pathology/radiology model. It directly competes with Dr Lal PathLabs on routine and specialty tests across metros and tier-2 cities, with a similar test menu, home collection, and franchise footprint.

TypeDirect peer
Description

SRL Diagnostics (rebranded as Agilus) is a pan-India diagnostic chain offering pathology and radiology with a network of labs and collection centres. It is a direct competitor to Dr Lal PathLabs across routine and specialty testing, hospital reference work, and preventive health packages.

TypeDirect peer
Description

Thyrocare is a preventive and wellness-focused diagnostic lab known for low-cost, high-volume test packages. Now owned by PharmEasy, it competes directly on bundled pricing for routine and preventive tests, particularly targeting price-sensitive Indian consumers.

TypeDirect peer
Description

Apollo Diagnostics is the diagnostics arm of Apollo Hospitals, offering pathology and imaging services across India. It competes with Dr Lal PathLabs across hospital-tied and standalone patient service centres, leveraging the Apollo brand and integrated care ecosystem.

TypeDirect peer
Description

Neuberg Diagnostics operates a network of pathology labs across India with strength in molecular diagnostics and integrated testing. It is comparable to Dr Lal PathLabs on test menu breadth, NABL/CAP-accredited reference labs, and South/West India footprint.

TypeRegional player
Description

Vijaya Diagnostic Centre is a leading diagnostic chain headquartered in Hyderabad with strong presence in South India. It offers comparable pathology and radiology services to Dr Lal PathLabs but with a primarily regional (South India) concentration.

TypeEmerging player
Description

Orange Health Labs is a tech-enabled, at-home diagnostic startup processing ~300,000 samples monthly. It targets the same urban, digital-first consumer segment as Dr Lal PathLabs with rapid home collection and digital reporting, pressuring on speed and convenience.

TypeEmerging player
Description

Healthians is an at-home diagnostic and wellness startup offering preventive health packages and online booking. It overlaps with Dr Lal PathLabs on the SwasthFit-style bundled health check-up category and the digital home-collection consumer.

TypeBroad incumbent
Description

Tata 1mg is a broad digital health platform offering diagnostics, e-pharmacy, and teleconsultation under the Tata group. It competes with Dr Lal PathLabs on online test booking, home collection, and bundling, leveraging the Tata brand and a much larger consumer-facing ecosystem.

TypeBroad incumbent
Description

Quest Diagnostics is one of the world's largest clinical laboratory networks, offering routine and advanced diagnostics globally. It is comparable to Dr Lal PathLabs on test menu, reference lab operations, and CAP-accredited quality standards, and serves as a global scale benchmark.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dr Lal PathLabs

Diagnostic Serviceslalpathlabs.com

Dr Lal PathLabs firmographics

Firmographics
Name
Dr Lal PathLabs
Legal name
Dr Lal PathLabs Limited
Website
https://lalpathlabs.com
Company type
Public
Founded year
1949
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Dr Lal PathLabs industry classification

Industry
Product category
Diagnostic Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
akta.pro secondary industries
Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Research & Trial Central Laboratories (HLAFAMAL)

Keywords

  • Diagnostic pathology services
  • Clinical laboratory testing
  • Preventive health checkups
  • Radiology imaging services
  • Corporate health screening

Where Dr Lal PathLabs is headquartered

Location

Headquarters

HQ city
Haryana
HQ country
India
HQ region
Asia

Offices5 records

Markets served

Dr Lal PathLabs business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Pathology and Diagnostic Testing Services: Core revenue from pathology tests including blood tests, pathology panels, and health check-up packages offered to individual consumers and corporate clients through network of labs and collection centres.
  2. Radiology and Imaging Services: Revenue from radiology services including MRI, CT scan, X-ray, ultrasound, ECG, echocardiography, and mammography offered at diagnostic centres.
  3. SwasthFit GLP-1 Subscription Program: Subscription-based monitoring program for Type 2 Diabetes and Obesity combining diagnostic testing with diet and exercise coaching. Four tiers ranging from 1-week to 12-month subscriptions.
  4. Corporate Healthcare Services: Employee health check-up programs, drug tests, food handler check-ups, and pre-employment examinations for corporate clients across India.
  5. Sovaaka Premium Wellness Services: Premium diagnostic experience centre offering personalized wellness programs, genetic testing, AI-supported imaging, and lifestyle-based healthcare with packages priced between Rs 11,000 and Rs 35,000.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goSwasthFit Super 1 - Basic wellness package with 34 parameters
Unit PricingPay-as-you-goSwasthFit Super 2 - Intermediate wellness package with 57 parameters
Unit PricingPay-as-you-goSwasthFit Super 3 - Advanced wellness package with 36 parameters
Unit PricingPay-as-you-goSwasthFit Super 4 - Premium wellness package with 59 parameters
Unit PricingPay-as-you-goSwasthFit Complete Health Check - Comprehensive package with 106 parameters
SubscriptionMonthlySwasthFit GLP Screen - 1 week subscription
SubscriptionMonthlySwasthFit GLP Monitor - 3 months subscription
SubscriptionMulti-year contractSwasthFit GLP Sustain - 6 months subscription
SubscriptionMulti-year contractSwasthFit GLP Total - 12 months subscription
Unit PricingPay-as-you-goAllergy Comprehensive Profile
Unit PricingPay-as-you-goRadiology Services - ECG/EKG
Unit PricingPay-as-you-goRadiology Services - Echocardiography

Go-to-market motion4 records

Distribution channels8 records

Marketing channels8 records

Dr Lal PathLabs product offering

Product offering

Core offering

Dr Lal PathLabs operates a pan-India diagnostic services network offering pathology and radiology testing through 290+ laboratories, 6,600+ patient service centres, and 12,300+ pick-up points. The company provides over 5,000 tests and panels including routine blood tests, molecular diagnostics, genetic testing, imaging services (MRI, CT, X-ray, ultrasound, ECG, echocardiography), and bundled preventive health check-up packages such as SwasthFit and the premium Sovaaka vertical. Revenue is generated primarily through per-test and package fees for individual consumers, corporate health programs, and home sample collection services.

Product overview

Dr Lal PathLabs operates as a comprehensive diagnostic services platform offering pathology and radiology testing across India. The core product portfolio includes SwasthFit bundled health checkup packages (Super 1-4, Complete Health Check), the AI-powered SwasthFit GLP-1 Program for diabetes and obesity management, and the premium wellness brand Sovaaka launched in January 2026. Supporting services include radiology imaging (MRI, CT, X-Ray, Ultrasound, Mammography, ECG, Echo), home collection, corporate tie-ups, and specialty testing programs including pregnancy packages, allergy testing, and the PrecisionCHD AI-enabled coronary heart disease test. The company processes samples through a network of 290+ clinical laboratories and over 6,600 patient service centres across India, with international operations in 14+ countries.

Differentiator

Problem solved

Functional benefit

Brands

  • Sovaaka: Premium wellness vertical / Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Programs include Eterna for women and Vita for men.
  • SwasthFit

Products and services

  • Pathology Tests Core diagnostic testing service offering over 5,000 tests and panels including blood tests, metabolic panels, infectious disease testing, cancer screening, genetic testing, molecular diagnostics, and specialized pathology services across all major disease categories. For individual consumers, hospitals, and referring doctors.
  • Radiology Services Comprehensive medical imaging services including MRI, CT Scan, X-Ray, Ultrasound, Mammography, ECG, Echo/2D Echo, TMT (Treadmill Test), Stress Echo, Holter monitoring, Pulmonary Function Test, Uroflowmetry, and OPG dental imaging. Available across the Delhi/NCR network for individual consumers and referring physicians.
  • SwasthFit Health Check Packages Bundled health check-up packages including SwasthFit Super 1-4 (34-59 parameters) and SwasthFit Complete Health Check (106 parameters) covering diabetes, thyroid, heart health, and general wellness, with 40-49% discounts from list prices. Targeted at individual consumers for preventive screening.
  • SwasthFit GLP-1 Program Subscription-based monitoring program for Type 2 Diabetes and Obesity management combining structured diagnostic testing (85+ parameters) with AI-enabled food scanning, face scan technology, dietician consultations, and exercise coaching. Four subscription tiers (1 week to 12 months) priced from Rs 6,500 to Rs 21,500. For individual consumers managing metabolic conditions.
  • Sovaaka Premium Wellness Premium Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Doctor-designed programs include Eterna for women and Vita for men, with services like low-dose CT, 1.5T MRI, and DEXA scanning. Packages priced between Rs 11,000 and Rs 35,000. For affluent, wellness-focused consumers.
  • Pregnancy Packages Specialized trimester-based pregnancy testing packages covering first, second, and third trimester including Pregnancy Package-6 (55 parameters) and Pregnancy Package-7 (42 parameters), for expectant mothers and obstetricians.
  • Allergy Testing Comprehensive allergy testing including Allergy Comprehensive Profile (Rs 13,790 covering 100+ allergens), Food Intolerance Test (214 parameters), Immunoglobulin IgE, and specialized panels for dust, mold, milk, and food allergens. Over 100 allergy test types available. For individual consumers and referring physicians.
  • Oncopro Cancer Diagnostics Oncology-focused diagnostic program offering cancer screening, tumor marker panels, and specialized oncology testing under the Oncopro brand, for individual consumers and referring oncologists.
  • Diabetic Care Program Structured diabetes care program combining diagnostic testing, monitoring, and lifestyle guidance for individuals managing Type 1 and Type 2 diabetes.
  • Home Collection Service Home sample collection service allowing patients to book home visits for pathology sample collection. Includes prescription upload and callback request for test booking assistance, supporting convenience for individual consumers and elderly or mobility-limited patients.
  • Corporate Health Programs Corporate health screening solutions including annual checkups, pre-employment checkups, drug tests, food handler checkups, and COVID-related testing, with customized packages for corporate employees and families, available on-site and off-site. For HR teams, EHS functions, and corporate administration.
  • PrecisionCHD Test Clinical blood test using epigenetics, genetics, and AI to detect coronary heart disease at the molecular level, including non-obstructive forms that standard angiograms typically cannot identify. Launched in January 2026 in partnership with Cardio Diagnostics and Aimil Ltd. for individual consumers and cardiologists.

Quantifiable outcome

  • 85.6M+ samples collected with 50+ quality checks per sample
  • +3 more outcomes

Companies that use Dr Lal PathLabs

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Dr Lal PathLabs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability7 records

Feature5 records

Dr Lal PathLabs partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered strategic, core and minor.

  • Cardio Diagnostics Holdings, Inc.strategicStrategic or Co-development Partner · 7 January 2026Strategic partnership to launch the PrecisionCHD test in India for detecting and managing coronary heart disease. This is Cardio Diagnostics' first expansion outside the United States. The test uses epigenetics, genetics, and AI technology to detect CHD at the molecular level, including non-obstructive forms that standard angiograms cannot identify. Initial phase integration into Dr. Lal PathLabs' network of over 290 clinical laboratories with commercial rollout expected in 2026.
  • Aimil Ltd.strategicStrategic or Co-development Partner · 7 January 2026Tripartite partnership with Cardio Diagnostics and Aimil Ltd. to launch PrecisionCHD test in India. Aimil serves as a distribution and implementation partner for the technology in the Indian market.
  • Siemens HealthineerscoreTechnology or IntegrationDigital transformation partnership implementing the Atellica Solution, Aptio Automation, and integrated IT tools at Dr. Lal PathLabs' national reference lab in Delhi. The implementation enabled reduction of total automation turnaround time by over 50%, reduced sample splitting by 93%, and improved Six Sigma assay performance. Partnership enables scalable, standardized workflows across the vast lab network.
  • ABDM (Ayushman Bharat Digital Mission)coreStrategic or Co-development PartnerIntegration with India's national digital health ecosystem, enabling patients to create ABHA (Ayushman Bharat Health Account) numbers and link their medical records. The platform supports 333M+ ABHA addresses created and 235M+ health records linked, enhancing digital health accessibility.
  • International Partner NetworkminorChannel Partner/ Reseller/ DistributorPartnership network in 14+ countries operating 90+ partners including hospitals and laboratories. Enables diagnostic services for patients and healthcare providers across international markets with 420+ tests per day conducted internationally.

Scale indicators14 records

Recent moves8 records

Expansion highlights6 records

Dr Lal PathLabs competitors and assessment

Company assessment

Direct peers

  • Metropolis Healthcare: Metropolis Healthcare is one of India's leading diagnostic chains with a comparable B2C and B2B pathology/radiology model. It directly competes with Dr Lal PathLabs on routine and specialty tests across metros and tier-2 cities, with a similar test menu, home collection, and franchise footprint.
  • SRL Diagnostics (Agilus Diagnostics): SRL Diagnostics (rebranded as Agilus) is a pan-India diagnostic chain offering pathology and radiology with a network of labs and collection centres. It is a direct competitor to Dr Lal PathLabs across routine and specialty testing, hospital reference work, and preventive health packages.
  • Thyrocare Technologies: Thyrocare is a preventive and wellness-focused diagnostic lab known for low-cost, high-volume test packages. Now owned by PharmEasy, it competes directly on bundled pricing for routine and preventive tests, particularly targeting price-sensitive Indian consumers.
  • Apollo Diagnostics: Apollo Diagnostics is the diagnostics arm of Apollo Hospitals, offering pathology and imaging services across India. It competes with Dr Lal PathLabs across hospital-tied and standalone patient service centres, leveraging the Apollo brand and integrated care ecosystem.
  • Neuberg Diagnostics: Neuberg Diagnostics operates a network of pathology labs across India with strength in molecular diagnostics and integrated testing. It is comparable to Dr Lal PathLabs on test menu breadth, NABL/CAP-accredited reference labs, and South/West India footprint.

Regional players

  • Vijaya Diagnostic Centre: Vijaya Diagnostic Centre is a leading diagnostic chain headquartered in Hyderabad with strong presence in South India. It offers comparable pathology and radiology services to Dr Lal PathLabs but with a primarily regional (South India) concentration.

Emerging players

  • Orange Health Labs: Orange Health Labs is a tech-enabled, at-home diagnostic startup processing ~300,000 samples monthly. It targets the same urban, digital-first consumer segment as Dr Lal PathLabs with rapid home collection and digital reporting, pressuring on speed and convenience.
  • Healthians: Healthians is an at-home diagnostic and wellness startup offering preventive health packages and online booking. It overlaps with Dr Lal PathLabs on the SwasthFit-style bundled health check-up category and the digital home-collection consumer.

Broad incumbents

  • Tata 1mg (Tata Digital): Tata 1mg is a broad digital health platform offering diagnostics, e-pharmacy, and teleconsultation under the Tata group. It competes with Dr Lal PathLabs on online test booking, home collection, and bundling, leveraging the Tata brand and a much larger consumer-facing ecosystem.
  • Quest Diagnostics: Quest Diagnostics is one of the world's largest clinical laboratory networks, offering routine and advanced diagnostics globally. It is comparable to Dr Lal PathLabs on test menu, reference lab operations, and CAP-accredited quality standards, and serves as a global scale benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Dr Lal PathLabs social profiles

Digital presence

Dr Lal PathLabs compliance and trust

Trust signal

Compliance5 records

Dr Lal PathLabs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dr Lal PathLabs leadership team

Management profile

Number of profiles

Profiles14 records

Dr Lal PathLabs subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Dr Lal PathLabs funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dr Lal PathLabs M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr Lal PathLabs

What does Dr Lal PathLabs do?

Dr Lal PathLabs operates a pan-India diagnostic services network offering pathology and radiology testing through 290+ laboratories, 6,600+ patient service centres, and 12,300+ pick-up points. The company provides over 5,000 tests and panels including routine blood tests, molecular diagnostics, genetic testing, imaging services (MRI, CT, X-ray, ultrasound, ECG, echocardiography), and bundled preventive health check-up packages such as SwasthFit and the premium Sovaaka vertical. Revenue is generated primarily through per-test and package fees for individual consumers, corporate health programs, and home sample collection services.

Is Dr Lal PathLabs a public or private company?

Dr Lal PathLabs is a public company. It is classified as public and is currently operating.

When was Dr Lal PathLabs founded?

Dr Lal PathLabs was founded in 1949. It employs 1,001 to 5,000 people.

Where is Dr Lal PathLabs based?

Dr Lal PathLabs is headquartered in Haryana, India, in the Asia region.

How does Dr Lal PathLabs make money?

Five revenue lines are on record. Pathology and Diagnostic Testing Services are the primary driver. The others are radiology and Imaging Services, swasthFit GLP-1 Subscription Program, corporate Healthcare Services and sovaaka Premium Wellness Services.

Who are Dr Lal PathLabs's main competitors?

Direct peers on record are Metropolis Healthcare, SRL Diagnostics (Agilus Diagnostics), Thyrocare Technologies, Apollo Diagnostics and Neuberg Diagnostics. Vijaya Diagnostic Centre is listed as a regional player. Emerging players are Orange Health Labs and Healthians. Broad incumbents are Tata 1mg (Tata Digital) and Quest Diagnostics.

Does Dr Lal PathLabs have an API?

No public API is recorded for Dr Lal PathLabs.

What industry is Dr Lal PathLabs in?

Dr Lal PathLabs's product category is Diagnostic Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business StandardCrisis-proofing the corporationA book review examines five BSE500 companies—Bajaj Finance, Titan, Dr Lal PathLabs, Divi's Labs, and Tata Elxsi—that outperformed GDP growth and returned over 15% annually during 2015-2025. The authors attribute their success to long-term vision, innovation, brand, architecture, and strategic assets, offering best practices for entrepreneurs.Business News TodayTrade Spotlight: How should you trade Zensar Tech, Netweb Tech, Action Construction Equipment, Dr Lal PathLabs, Hero MotoCorp, and others on October 6?- Moneycontrol.comMoneycontrol's trade spotlight offers short-term trading ideas for several stocks on October 6, including Zensar, Netweb, and others. It recommends buying Zensar, Netweb, and Action Construction Equipment, while selling Dixon Technologies, BPCL, and Hero MotoCorp futures, with specific targets and stop-losses.Business TodayZydus Life, Sona Comstart Dr Lal Pathlabs: Top stocks to trade Price targets, stop loss & more - BusinessTodayVishnu Kant Upadhyay of Master Capital Services recommended Dr Lal Pathlabs, Sona Comstart, and Zydus Lifesciences for short-term gains, citing bullish chart patterns. He set target prices of Rs 2,140-2,180, Rs 870-900, and Rs 1,220-1,250, with stop losses at Rs 1,870, Rs 755, and Rs 1,085 respectively.Business News TodayTrade Spotlight: How should you trade Gujarat Pipavav Port, Sona BLW, Action Construction Equipment, Dr Lal PathLabs, and others on October 1?- Moneycontrol.comMoneycontrol's technical analysts offer short-term trading ideas for several stocks, including Gujarat Pipavav Port, Sona BLW, and Dr Lal PathLabs, with buy targets and stop-losses. Divis Laboratories is flagged for a sell, with a target of Rs 9,100 and stop-loss at Rs 9,500. The advice is based on technical indicators and price action.MintDr Lal PathLabs adds genomics heft with SN Genelab dealDr Lal PathLabs is acquiring 70% of SN Genelab for ₹168 crore, with an additional ₹31.5 crore payable if performance targets are met. SN Genelab's FY26 revenue was ₹58 crore, just 2% of Dr Lal's, so an immediate boost is ruled out. The deal may be marginally earnings-dilutive but could expand testing reach over 2-3 years.Medical BuyerDr. Lal PathLabs acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs' Dubai subsidiary completed an 80% stake acquisition in Ghana's Sunshine Healthcare Ltd. The deal makes Sunshine Healthcare a step-down subsidiary of Dr Lal PathLabs, with the transaction completed under Ghana's applicable provisions.ET NOWDr Lal PathLabs acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs completed the acquisition of an 80% stake in Ghana's Sunshine Healthcare, with its Dubai subsidiary paying up to GHS 45.6 million. The deal strengthens Dr Lal PathLabs' West African diagnostic presence, and Sunshine Healthcare reported FY26 turnover of Rs 24.4 crore.BusinessLineDr Lal PathLabs’ subsidiary acquires 80% stake in Ghana’s Sunshine HealthcareDr Lal PathLabs' subsidiary Dr Lal PathLabs FZCO completed an 80% stake acquisition in Ghana's Sunshine Healthcare Ltd. The transaction made Sunshine Healthcare a step-down subsidiary of Dr Lal PathLabs, completed in accordance with Ghana's provisions.BusinessLineBroker’s call: Dr Lal PathlabsDr Lal Pathlabs acquired SN Genelab, a B2B diagnostics operator, for ₹168 crore (70% stake), valuing it at 16x FY26 EV/EBITDA. The company expects revenue synergies over 2-3 years and raised its Sep-27E price target to ₹2,100 from ₹2,000.Business StandardDr Lal PathLabs expands advanced diagnostics portfolio with genomics buyDr Lal PathLabs acquired a 70% stake in SN Genelab for ₹168 crore, strengthening its genomics portfolio. The Gujarat-based company's revenues grew from ₹43 crore to ₹58 crore, with operating profit doubling to ₹15 crore. Brokerages see the deal at attractive valuations, with integration expected over two to three years.